We are live on ! Find out more
DFTX

Definium Therapeutics

151 hedge funds and large institutions have $299M invested in Definium Therapeutics in 2024 Q2 according to their latest regulatory filings, with 44 funds opening new positions, 39 increasing their positions, 24 reducing their positions, and 27 closing their positions.

New
Increased
Maintained
Reduced
Closed

282% more call options, than puts

Call options by funds: $14.4M | Put options by funds: $3.77M

63% more first-time investments, than exits

New positions opened: 44 | Existing positions closed: 27

63% more repeat investments, than reductions

Existing positions increased: 39 | Existing positions reduced: 24

12% more funds holding

Funds holding: 135151 (+16)

9% less capital invested

Capital invested by funds: $327M → $299M (-$28.2M)

25% less funds holding in top 10

Funds holding in top 10: 43 (-1)

26.45% less ownership

Funds ownership: 84.24%57.79% (-26%)

Holders
151
Holders Change
+16
Holders Change %
+11.85%
% of All Funds
2.18%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.04%
New
44
Increased
39
Reduced
24
Closed
27
Calls
$14.4M
Puts
$3.77M
Net Calls
+$10.6M
Net Calls Change
-$11.6M
Name Holding Trade Value Shares
Change
Change in
Stake
SFA
76
Sequoia Financial Advisors
Ohio
$120K -$10.7K -1,224 -7%
ASRS
77
Arizona State Retirement System
Arizona
$114K +$138K +15,789 New
FC
78
Fore Capital
New York
$108K +$131K +15,000 New
Mercer Global Advisors
79
Mercer Global Advisors
Colorado
$105K -$3.57K -408 -3%
HighTower Advisors
80
HighTower Advisors
Illinois
$104K +$127K +14,530 New
RJFSA
81
Raymond James Financial Services Advisors
Florida
$92.2K -$8.51K -973 -7%
Teacher Retirement System of Texas
82
Teacher Retirement System of Texas
Texas
$89K +$108K +12,389 New
Fidelity Investments
83
Fidelity Investments
Massachusetts
$84.6K -$112K -12,849 -52%
William Blair & Company
84
William Blair & Company
Illinois
$81.2K -$638 -73 -0.6%
WA
85
Wealth Alliance
New York
$79.3K +$96.2K +11,000 New
DWM
86
Diversify Wealth Management
Utah
$74.7K +$87.5K +10,000 New
BAG
87
Bridgewealth Advisory Group
California
$72.1K +$87.5K +10,000 New
Thrivent Financial for Lutherans
88
Thrivent Financial for Lutherans
Minnesota
$72K
Simplex Trading
89
Simplex Trading
Illinois
$63K -$402K -46,007 -84%
AIP
90
Ameritas Investment Partners
Nebraska
$50.9K +$61.7K +7,053 New
ACM
91
Aquatic Capital Management
Illinois
$47.6K +$57.7K +6,600 New
TWC
92
TD Waterhouse Canada
Ontario, Canada
$32K -$341 -39 -0.9%
Osaic Holdings
93
Osaic Holdings
Arizona
$30.5K +$4.31K +493 +13%
TRCT
94
Tower Research Capital (TRC)
New York
$21.8K -$24K -2,745 -48%
NSIM
95
North Star Investment Management
Illinois
$18K +$3.06K +350 +16%
AB
96
Amalgamated Bank
New York
$18K +$21.8K +2,491 New
IA
97
IFP Advisors
Florida
$14.4K +$17.2K +1,970 +6,567%
CA
98
Crewe Advisors
Utah
$14.4K
National Bank of Canada
99
National Bank of Canada
Quebec, Canada
$12.3K
QT
100
Quantbot Technologies
New York
$11.4K +$13.8K +1,577 New

DFTX Hedge Fund Activity: Q2 2024 in Review

151 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Definium Therapeutics (DFTX) for Q2 2024, worth a combined $299M — down 8.6% from $327M a quarter earlier.

Buyers outnumbered sellers: 44 funds opened new DFTX positions and 27 closed out — a net gain of 17 holders — while 39 added to existing stakes and 24 trimmed.

The largest buyer was BlackRock, adding an estimated $40.1M. The largest seller was Great Point Partners, exiting entirely with an estimated $18.8M sold.

  • 151 institutional investors held Definium Therapeutics (DFTX) as of Q2 2024, up from 135 in Q1 2024.
  • Funds reported $299M of Definium Therapeutics stock for Q2 2024, down 8.6% quarter-over-quarter.
  • 44 funds opened new Definium Therapeutics positions in Q2 2024 and 27 closed out, a net change of +17 holders.
  • The largest Definium Therapeutics buyer in Q2 2024 was BlackRock, an estimated $40.1M added.
  • The largest Definium Therapeutics seller in Q2 2024 was Great Point Partners, an estimated $18.8M sold.

Based on aggregated 13F filings for Q2 2024.